ArticleScandinavian journal of medicine & science in sports2026
Baseline Inflammatory Markers as Predictors of Running-Related Injuries: A One-Year Prospective 4HAIE Cohort Study.
Article in Scandinavian journal of medicine & science in sports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ankle Joint Biomechanics in Recreational Runners with Resolved and Incident Plantar Fasciitis: A One-Year Prospective 4HAIE Cohort Study.Scandinavian journal of medicine & science in sports · 2026Article
- Baseline Inflammatory Markers as Predictors of Running-Related Injuries: A One-Year Prospective 4HAIE Cohort Study.Scandinavian journal of medicine & science in sports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Inflammatory processes may contribute to running-related injury (RRI) susceptibility, yet the predictive value of baseline inflammatory biomarkers remains unclear. This prospective study investigated whether baseline biochemical markers of inflammation predict RRI occurrence in healthy individuals over 1 year, while accounting for training, physiological, and injury history variables. A total of 1315 healthy individuals (recreational runners and inactive controls) were followed for 12 months with prospective injury surveillance. Baseline blood samples were analyzed for inflammatory markers. Multivariable logistic regression examined associations between baseline biomarkers and RRI occurrence, adjusting for age, sex, peak oxygen consumption, weekly running distance, total body fat, and history of musculoskeletal trauma. Significant predictors of RRI included baseline tumor necrosis factor alpha (TNF-α) (OR per 1 pg/mL: 1.25, 95% CI: 1.08-1.44), history of musculoskeletal trauma (OR: 1.42, 95% CI: 1.06-1.90), weekly running distance, and age. Interleukin-1 receptor antagonist (IL-1RA) showed a modest protective association (OR per 10 pg/mL: 0.99, 95% CI: 0.99-1.00). However, the model demonstrated limited discriminatory ability (AUC = 0.66), indicating that baseline inflammatory markers alone are insufficient for individual-level injury prediction. Baseline TNF-α and IL-RA are significantly associated with RRI occurrence, suggesting that inflammatory phenotype contributes to injury susceptibility. However, TNF-α and IL-1RA cannot serve as reliable standalone screening tools, and our findings indicate that baseline inflammatory phenotype represents one component of multifactorial injury risk. While baseline TNF-α and IL-1RA measurements are unlikely to transform clinical practice in isolation, understanding inflammatory contributions to injury susceptibility may inform more effective injury-prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.